NCT00003225 - Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 1997

Primary Completion Date

March 31, 2000

Study Completion Date

June 30, 2001

Conditions

Colorectal Cancer

Interventions

DRUG

amifostine trihydrate

Ethyol 740 mg/m2 will be administered intravenously over 10 minutes. Administered every two weeks for 3 cycles.

DRUG

irinotecan hydrochloride

"10 minutes after completion of the Ethyol infusion, Irinotecan 250 mg/m2 will be given over 90 minutes IV.~Administered every 14 days for 3 cycles"

Trial Locations (2)

Wilshire Oncology Medical Group, Inc., Rancho Cucamonga

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles